scPharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview

Scpharmaceuticals

09/08/2021 13:51

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected to show a
no change in quarterly revenue when it reports results on August
11 (estimated). 
​* Refinitiv's mean analyst estimate for scPharmaceuticals Inc
is for a loss of 30 cents per share. For the same quarter last
year, the company reported a loss of 36 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for
scPharmaceuticals Inc is $13​, about 57.9% above​ its last
closing price of $5.47. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.30       -0.30      -0.26     Beat    13.3
 Dec. 31 2020  -0.36       -0.36      -0.28     Beat    22.9
 Sep. 30 2020  -0.38       -0.38      -0.33     Beat    13.7​
 Jun. 30 2020  -0.42       -0.42      -0.36     Beat    14.8
 Mar.          -0.53​      -0.54      -0.35     Beat    34.9​
 31​ 2020​                                              
 Dec. 31 2019              -0.52      -0.58     Missed  -10.5​
 Sep. 30 2019  -0.45       -0.45      -0.33     Beat    26.3
 Jun. 30 2019  -0.48       -0.49      -0.39     Beat    19.9
 This summary was machine generated August 9 at 12:51 GMT.  All
figures in US dollars unless otherwise stated